Hospital Universitario del Henares
- Address
- Avenida De Marie Curie S/n, 28822 Coslada (Madrid), Spain
Respiratory Tract Diseases at Hospital Universitario del Henares
This Pulmonology research program focuses on respiratory tract diseases, with clinical trials centered on idiopathic pulmonary fibrosis and progressive pulmonary fibrosis. The studies are designed to assess whether new treatment approaches can help preserve lung function and improve outcomes for people living with these serious lung conditions.
- Research on idiopathic pulmonary fibrosis aims to better understand treatment effectiveness and support patients with a chronic, scarring lung disease.
- Trials in progressive pulmonary fibrosis are evaluating whether investigational therapies can slow disease progression and improve breathing-related health.
With a small but focused portfolio of 2 clinical trials and 7 investigators, the site is contributing to advances in care for fibrotic lung disease in Coslada, Spain.
Fibrotic Lung Disease Research
Clinical research at this health care institution is concentrated on conditions that cause scarring and gradual loss of lung capacity. The main goal is to evaluate new therapies for their ability to improve or maintain forced vital capacity, an important measure of lung function in patients with fibrotic lung disease.
- Idiopathic pulmonary fibrosis studies are examining whether investigational treatment can improve lung function over time.
- Progressive pulmonary fibrosis trials are assessing treatment benefit in patients whose disease continues to worsen despite standard care.
This research reflects a strong emphasis on testing the efficacy, safety, and tolerability of new options for patients seen at Hospital Universitario del Henares.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Universitario del Henares
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis | Bristol-Myers Squibb Services Unlimited Company | Phase III | Not Yet Recruiting | Jun 2024 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| ADMILPARANT | 3 | Unknown | 2024-06-24 | 2024-07-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.